KELLI MCKAY: Open Payments
NPI 1679088116 · AUBURN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 15 payments from 5 companies in 2025. Trend: 2023 $165 · 2024 $366 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 10 | $291 |
| ABBVIE INC. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| Amgen Inc. | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Bimzelx, SKYRIZI, ENBREL, SAPHNELO.
Industry payments across AL — which companies pay providers there.
